Tumor-induced escape mechanisms and their association with resistance to checkpoint inhibitor therapy
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tumor-induced escape mechanisms and their association with resistance to checkpoint inhibitor therapy
Authors
Keywords
Tumor, Immune escape, MHC, Immunotherapy, Resistance, TIMO XIV
Journal
CANCER IMMUNOLOGY IMMUNOTHERAPY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-08-03
DOI
10.1007/s00262-019-02373-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Defective HLA class I antigen processing machinery in cancer
- (2018) Lei Cai et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- The RNA-binding Protein MEX3B Mediates Resistance to Cancer Immunotherapy by Downregulating HLA-A Expression
- (2018) Lu Huang et al. CLINICAL CANCER RESEARCH
- Prevalent Homozygous Deletions of Type I Interferon and Defensin Genes in Human Cancers Associate with Immunotherapy Resistance
- (2018) Zhenqing Ye et al. CLINICAL CANCER RESEARCH
- Tumor-dependent effects of proteoglycans and various glycosaminoglycan synthesizing enzymes and sulfotransferases on patients’ outcome
- (2018) Karthikeyan Subbarayan et al. CURRENT CANCER DRUG TARGETS
- microRNA 125a Regulates MHC-I Expression on Esophageal Adenocarcinoma Cells, Associated With Suppression of Anti-tumor Immune Response and Poor Outcomes of Patients
- (2018) Luigi Mari et al. GASTROENTEROLOGY
- IFN-γ orchestrates tumor elimination, tumor dormancy, tumor escape, and progression
- (2018) Hussein F. Aqbi et al. JOURNAL OF LEUKOCYTE BIOLOGY
- TEIPP antigens for T-cell based immunotherapy of immune-edited HLA class I low cancers
- (2018) Koen A. Marijt et al. MOLECULAR IMMUNOLOGY
- Cell Surface MHC Class I Expression Is Limited by the Availability of Peptide-Receptive “Empty” Molecules Rather than by the Supply of Peptide Ligands
- (2018) Liran Komov et al. PROTEOMICS
- Emerging Role of Immunotherapy in Advanced Urothelial Carcinoma
- (2018) Vadim S. Koshkin et al. Current Oncology Reports
- DNMT1 regulates expression of MHC class I in post-mitotic neurons
- (2018) Julie Ry Gustafsson et al. Molecular Brain
- Interferon-Gamma at the Crossroads of Tumor Immune Surveillance or Evasion
- (2018) Flávia Castro et al. Frontiers in Immunology
- Biglycan-mediated upregulation of MHC class I expression in HER-2/neu-transformed cells
- (2018) Karthikeyan Subbarayan et al. OncoImmunology
- Pembrolizumab plus Chemotherapy for Squamous Non–Small-Cell Lung Cancer
- (2018) Luis Paz-Ares et al. NEW ENGLAND JOURNAL OF MEDICINE
- Acquired cancer resistance to combination immunotherapy from transcriptional loss of class I HLA
- (2018) K. G. Paulson et al. Nature Communications
- Heterogeneity of HLA-G Expression in Cancers: Facing the Challenges
- (2018) Aifen Lin et al. Frontiers in Immunology
- Immune checkpoint blockade resistance-related B2M hotspot mutations in microsatellite-unstable colorectal carcinoma
- (2018) Su Yeon Yeon et al. PATHOLOGY RESEARCH AND PRACTICE
- A functional SNP in the 3′-UTR of TAP2 gene interacts with microRNA hsa-miR-1270 to suppress the gene expression
- (2017) Bridgett Knox et al. ENVIRONMENTAL AND MOLECULAR MUTAGENESIS
- Mutation patterns in genes encoding interferon signaling and antigen presentation: A pan-cancer survey with implications for the use of immune checkpoint inhibitors
- (2017) Jan Budczies et al. GENES CHROMOSOMES & CANCER
- IFN-γ–related mRNA profile predicts clinical response to PD-1 blockade
- (2017) Mark Ayers et al. JOURNAL OF CLINICAL INVESTIGATION
- Posttranscriptional Regulation of HLA-A Protein Expression by Alternative Polyadenylation Signals Involving the RNA-Binding Protein Syncrip
- (2017) Smita Kulkarni et al. JOURNAL OF IMMUNOLOGY
- Immune Modulatory microRNAs Involved in Tumor Attack and Tumor Immune Escape
- (2017) Stefan B. Eichmüller et al. JNCI-Journal of the National Cancer Institute
- Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers
- (2017) Aaron M. Goodman et al. MOLECULAR CANCER THERAPEUTICS
- The regulatory network behind MHC class I expression
- (2017) Marlieke L.M. Jongsma et al. MOLECULAR IMMUNOLOGY
- Novel landscape of HLA-G isoforms expressed in clear cell renal cell carcinoma patients
- (2017) Diana Tronik-Le Roux et al. Molecular Oncology
- Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients
- (2017) Ahmet Zehir et al. NATURE MEDICINE
- Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
- (2017) Jedd D. Wolchok et al. NEW ENGLAND JOURNAL OF MEDICINE
- Programmatic access to bioinformatics tools from EMBL-EBI update: 2017
- (2017) Szymon Chojnacki et al. NUCLEIC ACIDS RESEARCH
- Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
- (2017) Dung T. Le et al. SCIENCE
- Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy
- (2017) Diego Chowell et al. SCIENCE
- Resistance to checkpoint blockade therapy through inactivation of antigen presentation
- (2017) Moshe Sade-Feldman et al. Nature Communications
- Immune Modulatory microRNAs Involved in Tumor Attack and Tumor Immune Escape
- (2017) Stefan B. Eichmüller et al. JNCI-Journal of the National Cancer Institute
- Epigenetic priming restores the HLA class-I antigen processing machinery expression in Merkel cell carcinoma
- (2017) Cathrin Ritter et al. Scientific Reports
- Defining cross presentation for a wider audience
- (2016) Christopher C Norbury CURRENT OPINION IN IMMUNOLOGY
- Proteoglycan neofunctions: regulation of inflammation and autophagy in cancer biology
- (2016) Liliana Schaefer et al. FEBS Journal
- Role of microRNAs on HLA-G expression in human tumors
- (2016) Barbara Seliger HUMAN IMMUNOLOGY
- The absence of HLA class I expression in non-small cell lung cancer correlates with the tumor tissue structure and the pattern of T cell infiltration
- (2016) Francisco Perea et al. INTERNATIONAL JOURNAL OF CANCER
- HNRNPR Regulates the Expression of Classical and Nonclassical MHC Class I Proteins
- (2016) Adi Reches et al. JOURNAL OF IMMUNOLOGY
- Molecular and Biochemical Aspects of the PD-1 Checkpoint Pathway
- (2016) Vassiliki A. Boussiotis NEW ENGLAND JOURNAL OF MEDICINE
- Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma
- (2016) Jesse M. Zaretsky et al. NEW ENGLAND JOURNAL OF MEDICINE
- Epstein–Barr virus microRNAs reduce immune surveillance by virus-specific CD8+T cells
- (2016) Manuel Albanese et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Proteomic screening identifies calreticulin as a miR-27a direct target repressing MHC class I cell surface exposure in colorectal cancer
- (2016) T Colangelo et al. Cell Death & Disease
- Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints
- (2016) Shohei Koyama et al. Nature Communications
- Evolution of Neoantigen Landscape during Immune Checkpoint Blockade in Non–Small Cell Lung Cancer
- (2016) Valsamo Anagnostou et al. Cancer Discovery
- Identification of novel microRNAs regulating HLA-G expression and investigating their clinical relevance in renal cell carcinoma
- (2016) Simon Jasinski-Bergner et al. Oncotarget
- Modulation of MHC class I surface expression in B16F10 melanoma cells by methylseleninic acid
- (2016) Claudia Lennicke et al. OncoImmunology
- Modulation of antigen presentation by intracellular trafficking
- (2015) Justine D Mintern et al. CURRENT OPINION IN IMMUNOLOGY
- Epigenetic regulation of differentialHLA-Aallelic expression levels
- (2015) Veron Ramsuran et al. HUMAN MOLECULAR GENETICS
- Cancer-Associated Oxidase ERO1-α Regulates the Expression of MHC Class I Molecule via Oxidative Folding
- (2015) Kazuharu Kukita et al. JOURNAL OF IMMUNOLOGY
- Human Leukocyte Antigen-G (HLA-G) Expression in Cancers: Roles in Immune Evasion, Metastasis and Target for Therapy
- (2015) Aifen Lin et al. MOLECULAR MEDICINE
- MicroRNA-148a inhibits the proliferation and promotes the paclitaxel-induced apoptosis of ovarian cancer cells by targeting PDIA3
- (2015) SHUZHEN ZHAO et al. Molecular Medicine Reports
- Clinical relevance of miR-mediated HLA-G regulation and the associated immune cell infiltration in renal cell carcinoma
- (2015) Simon Jasinski-Bergner et al. OncoImmunology
- Epigenetic regulations in the IFNγ signalling pathway: IFNγ-mediated MHC class I upregulation on tumour cells is associated with DNA demethylation of antigen-presenting machinery genes
- (2015) Veronika Vlková et al. Oncotarget
- Standard and immunoproteasomes show similar peptide degradation specificities
- (2014) Damien Zanker et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- In vivoevidence that secretion of HLA-G by immunogenic tumor cells allows their evasion from immunosurveillance
- (2014) Laure Loumagne et al. INTERNATIONAL JOURNAL OF CANCER
- The link between MHC class I abnormalities of tumors, oncogenes, tumor suppressor genes, and transcription factors
- (2014) Barbara Seliger Journal of Immunotoxicology
- MiR-451 Suppresses Cell Proliferation and Metastasis in A549 Lung Cancer Cells
- (2014) Pin Yin et al. MOLECULAR BIOTECHNOLOGY
- Going back to class I: MHC and immunotherapies for childhood cancer
- (2014) Kellie B. Haworth et al. PEDIATRIC BLOOD & CANCER
- Selenoproteins: Molecular Pathways and Physiological Roles
- (2014) Vyacheslav M. Labunskyy et al. PHYSIOLOGICAL REVIEWS
- MicroRNA Editing Facilitates Immune Elimination of HCMV Infected Cells
- (2014) Daphna Nachmani et al. PLoS Pathogens
- miR-9 modulates the expression of interferon-regulated genes and MHC class I molecules in human nasopharyngeal carcinoma cells
- (2013) Fei Gao et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Fine tuning type I interferon responses
- (2013) Paul J. Hertzog et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Dietary selenium supplementation modifies breast tumor growth and metastasis
- (2013) Yu-Chi Chen et al. INTERNATIONAL JOURNAL OF CANCER
- Immune escape of cancer cells with beta2-microglobulin loss over the course of metastatic melanoma
- (2013) Ana B. del Campo et al. INTERNATIONAL JOURNAL OF CANCER
- MHC Class I Antigen Processing and Presenting Machinery: Organization, Function, and Defects in Tumor Cells
- (2013) P. Leone et al. JNCI-Journal of the National Cancer Institute
- Genetic interplay between HLA-C and MIR148A in HIV control and Crohn disease
- (2013) S. Kulkarni et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Aberrant Calreticulin Expression Is Involved in the Dedifferentiation of Dedifferentiated Liposarcoma
- (2012) Masanori Hisaoka et al. AMERICAN JOURNAL OF PATHOLOGY
- The RNA-binding E3 ubiquitin ligase MEX-3C links ubiquitination with MHC-I mRNA degradation
- (2012) Florencia Cano et al. EMBO JOURNAL
- HER-2/neu-mediated Down-regulation of Biglycan Associated with Altered Growth Properties
- (2012) Christian V. Recktenwald et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Regulation of Class I Major Histocompatibility Complex (MHC) by Nucleotide-binding Domain, Leucine-rich Repeat-containing (NLR) Proteins
- (2012) Gregory R. Robbins et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Regulation of microRNA expression in the heart by the ATF6 branch of the ER stress response
- (2012) Peter J. Belmont et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- MiRNA-Mediated Control of HLA-G Expression and Function
- (2012) Irit Manaster et al. PLoS One
- Role of HLA-G in tumor escape through expansion of myeloid-derived suppressor cells and cytokinic balance in favor of Th2 versus Th1/Th17
- (2011) S. Agaugue et al. BLOOD
- Soluble HLA-G dampens CD94/NKG2A expression and function and differentially modulates chemotaxis and cytokine and chemokine secretion in CD56bright and CD56dim NK cells
- (2011) F. Morandi et al. BLOOD
- Association of IFN- Signal Transduction Defects with Impaired HLA Class I Antigen Processing in Melanoma Cell Lines
- (2011) A. Respa et al. CLINICAL CANCER RESEARCH
- Expression of HLA-G in patients with hepatocellular carcinoma
- (2011) Yan Wang et al. Hepatobiliary & Pancreatic Diseases International
- Dietary supplementation with methylseleninic acid, but not selenomethionine, reduces spontaneous metastasis of Lewis lung carcinoma in mice
- (2011) Lin Yan et al. INTERNATIONAL JOURNAL OF CANCER
- The Unfolded Protein Response (UPR)-activated Transcription Factor X-box-binding Protein 1 (XBP1) Induces MicroRNA-346 Expression That Targets the Human Antigen Peptide Transporter 1 (TAP1) mRNA and Governs Immune Regulatory Genes
- (2011) Rafal Bartoszewski et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Differential microRNA regulation of HLA-C expression and its association with HIV control
- (2011) Smita Kulkarni et al. NATURE
- Human cytomegalovirus microRNA miR-US4-1 inhibits CD8+ T cell responses by targeting the aminopeptidase ERAP1
- (2011) Sungchul Kim et al. NATURE IMMUNOLOGY
- Overexpression of miR-152 leads to reduced expression of human leukocyte antigen-G and increased natural killer cell mediated cytolysis in JEG-3 cells
- (2010) Xiao-ming Zhu et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Immune evasion of microsatellite unstable colorectal cancers
- (2010) Matthias Kloor et al. INTERNATIONAL JOURNAL OF CANCER
- Identification of E2F1 as an Important Transcription Factor for the Regulation of Tapasin Expression
- (2010) Juergen Bukur et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A Novel Mechanism of Soluble HLA-G Mediated Immune Modulation: Downregulation of T Cell Chemokine Receptor Expression and Impairment of Chemotaxis
- (2010) Fabio Morandi et al. PLoS One
- NLR family member NLRC5 is a transcriptional regulator of MHC class I genes
- (2010) T. B. Meissner et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Genetic and Epigenetic Control of the Major Histocompatibility Complex Class Ib Gene HLA-G in Trophoblast Cell Lines
- (2009) Tjadine M. Holling et al. Annals of the New York Academy of Sciences
- Molecular Mechanisms of IFN-γ to Up-Regulate MHC Class I Antigen Processing and Presentation
- (2009) Fang Zhou INTERNATIONAL REVIEWS OF IMMUNOLOGY
- RREB-1 Is a Transcriptional Repressor of HLA-G
- (2009) S. Flajollet et al. JOURNAL OF IMMUNOLOGY
- Different regulation of MHC Class I antigen processing components in human tumors
- (2009) Barbara Seliger Journal of Immunotoxicology
- Altered Detoxification Status and Increased Resistance to Oxidative Stress by K-Ras Transformation
- (2008) C. V. Recktenwald et al. CANCER RESEARCH
- Epigenetic Enhancement of Antigen Processing and Presentation Promotes Immune Recognition of Tumors
- (2008) A. F. Setiadi et al. CANCER RESEARCH
- HLA Class I Antigen Processing Machinery Component Expression and Intratumoral T-Cell Infiltrate as Independent Prognostic Markers in Ovarian Carcinoma
- (2008) L. Y. Han et al. CLINICAL CANCER RESEARCH
- Expression and regulation of non-classical HLA-G in renal cell carcinoma
- (2008) K. Dunker et al. TISSUE ANTIGENS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More